Salbupart
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Conclusions1.It has been shown experimentally and clinically that salbupart possesses a marked inhibitory action on uterine…
Clinical and experimental studies have revealed that salbupart, a beta-mimetic agent, administered in a dose of 0.14 mg/kg (the…
Comparative trials of two tocolytic preparations, salbupart (Polfa) and partusisten, showed their high efficacy (75 and 80 per…